17 October 2024
17 October 2024
Industry leaders explored the risks and benefits of adopting a China Plus One strategy at Advamed’s The MedTech Conference in Toronto.
WIMAGINE BCI is a key component of CEA’s ARC-BCI system, aiming to restore movement in paralysis patients.
Optune Lua received FDA approval based on data from the pivotal LUNAR trial which demonstrated significant median OS improvement.
The test has a 99% negative predictive value and features longitudinal monitoring.
With its pulsed-field ablation system approved in the EU and US, Boston Scientific aims to lead the pack in atrial fibrillation treatment.
After a two-year delay, J&J is ready to disrupt Intuitive’s market domination with Da Vinci.
Theranostics pairs diagnostic tracers with radioisotopes to deliver molecular insights specific to a patient’s cancer cells.
A variety of AI models are being trained on cough sounds for the early detection of tuberculosis.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
